26 September 2023 - The agenda for this week's HTA Review Reference Committee meeting is now available.
Finally, there are some interesting insights from the agenda.
The attendee list included a delegation from France and representatives from the local innovate pharmaceutical industry and a small number of consultants. What did they hear/discuss?